Mirtazapine Tablet, Film Coated
Product Images NDC 51407-351

4 FDA label images from Golden State Medical Supply, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 51407-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-350-10.jpg (51407 350 10)

51407-350-10.jpg (51407 350 10)
Label for Mirtazapine 15 mg tablets, USP, film-coated, oral dosage form. The label indicates a supply of 1,000 tablets and includes the National Drug Code (NDC) 51407-350-10. Manufactured by GSMS Incorporated, the label features storage instructions and notes the prescription-only status (Rx only).*
FDA Label Image

51407-351-05.jpg (51407 351 05)

51407-351-05.jpg (51407 351 05)
Packaging label for Mirtazapine tablets USP, 30 mg strength, containing 500 film-coated tablets. The label includes the NDC number 51407-351-05 and states the product is provided by Golden State Medical Supply, Inc. It indicates storage instructions at 20° to 25°C and notes the product is prescription only (Rx only). Additional warnings about container closure and dispensing instructions are partially visible.*
FDA Label Image

51407-352-05.jpg (51407 352 05)

51407-352-05.jpg (51407 352 05)
Label for Mirtazapine tablets, USP 45 mg, film coated, oral dosage form, containing 500 tablets. The label shows the NDC number 51407-352-05, with instructions to see package insert for dosage information. Manufactured by Golden State Medical Supply, Inc. The label includes storage instructions and cautions, along with a barcode and QR code.*
FDA Label Image

Mirtazapine Structural Formula (Image 04)

Mirtazapine Structural Formula (Image 04)
Chemical structure diagram of mirtazapine, showing its multi-ring system including a pyridine ring and a methylated nitrogen-containing ring, consistent with the molecular framework of the active ingredient mirtazapine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.